Dermatomyositis: Analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo, Brazil

Anais Brasileiros de Dermatologia

Volumn 89, Issue 5, 2014, Pages 719-727

  Ortigosa, Luciena Cegatto Martins ^a   dos Reis, Vitor Manuel Silva ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Clinical diagnosis; Dermatomyositis; Mortality

Indexed keywords

ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; AGED; BIOPSY; BRAZIL; CHILD; CLASSIFICATION; COMPLICATION; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; ELECTROMYOGRAPHY; FEMALE; HUMAN; MALE; MEDICAL RECORD; MIDDLE AGED; NEOPLASM; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; SKELETAL MUSCLE; SKIN; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY; BRAZIL; CHILD; CHILD, PRESCHOOL; CONNECTIVE TISSUE DISEASES; DERMATOMYOSITIS; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; MUSCLE, STRIATED; NEOPLASMS; PROGNOSIS; SKIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84906903877     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/abd1806-4841.20143422     Document Type: Article

References (62)

1. Kimball AB, Summers RM, Turner M, Dugan EM, Hicks J, Miller FW, Rider LG, et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenilederma-tomyositis. Implications for diagnosis and therapy. Arthritis Rheum. 2000;43:1866-73.
2. Koler RA, Montemarano A. Dermatomyositis. Am Fam Physician. 2001;64:1565-72.
3. Ortigosa LCM, Romiti R. Dermatomiosite. In: Belda JW, Chiacchio ND, Criado PR. Tratado de Dermatologia. São Paulo: Atheneu; 2000. p.735-54.
4. Boham A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344-7.
5. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for dermatomyositis. American Academy of Dermatology. J Am Acad Dermatol. 1996;34:824-9.
6. Callen JP. Dermatomyositis: diagnosis, evaluation and management. Minerva Med. 2002;93:157-67.
7. Bohan A, Peter JB, Bowman RL, Pearson CM. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore). 1977;56:255-86.
8. Tymms KE, Webb J. Dermatopolymyositis and others connective tissue diseases: a review of 105 cases. J Rheumatol. 1985;12:1140-8.
9. Koh ET, Seow A, Ong B, Ratnagopal P, Tjia H, Chng HH. Adult onset polymyositis/dermatomyo-sitis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis. 1993;52:857-61.
10. Oddis CV, Conte CG, Steen VD, Medsger TA Jr. Incidence of polymyositis-dermatomyositis: a 20 years study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol. 1990;17:1329-34.
11. Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM. Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol. 1996;14:263-74.
12. Dawkins MA, Jorizzo JL, Walker FO, Albertson D, Sinal SH, Hinds A. Dermatomyositis: a dermatology-based case series. J Am Acad Dermatol. 1998;38:397-404.
13. Scola RH, Werneck LC, Prevedello DM, Toderke EL, Iwamoto FM. Diagnosis of dermatomyo-sitis and polymyositis. A study of 102 cases. Arq Neuropsiquiatr. 2000;58:789-99.
14. Mahil S, Marks D, McCormack M, Rahman A. Dermatomyositis. Br J Hosp. (Lond) 2012;73:C18-22.
15. Na SJ, Kim SM, Sunwoo IN, Choi YC. Clinical characteristics and outcomes of juvenile and adult dermatomyositis. J Korean Med Sci. 2009;24:715-21.
16. Schiopu E, Phillips K, MacDonald PM, Crofford LJ, Somers EC. Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticoids, methotrexate and azathioprine. Arthritis Res Ther. 2012;14:R22.
17. Yosipovitch G, Tan A, LoSicco K, Manabat CG, Kannagra A, Carroll C, et al. A comparative study of clinical characteristics, work-up, treatment, and association to malignancy in derma-tomyositis between two tertiary skin centers in the USA and Singapore. Int J Dermatol. 2013;52:813-9.
18. Adams-Gandhi LB, Boyd AS, King LE Jr. Diagnosis and management of dermatomyositis. Compr Ther. 1996;22:156-64.
19. Pellissier J F, Civatte M, Fernandez C, Bartoli C, Chetaille B, Schleinitz N, et al. Dermatomyositis and polymyositis. Rev Neurol (Paris). 2002;158:934-47.
20. Benbassat J, Gefel D, Larholt K, Sukenik S, Morgenstern V, Zlotnick A. Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum. 1985;28:249-55.
21. Parodi A, Caproni M, Marzano AV, De Simone C, La Placa M, Quaglino P, et al. Dermatomyositis in 132 patients with different clinical subtypes: cutaneous signs, constitutional symptoms and circulating antibodies. Acta Derm Venereol. 2002;82:48-51.
22. See Y, Giam YC, Chung HH. A retrospective study of 13 oriental children with juvenile derma-tomyositis. Ann Acad Med Singapore. 1997;26:210-4.
23. Pachman LM, Hayford JR, Chung A, Daugherty CA, Pallansch MA, Fink CW, et al. Juvenile derma-tomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol. 1998;25:1198-204.
24. Sallazar-Paramo M, Gonzáles-Covarrubias I, Garcia-De La Torre I. Características clínicas e sorológicas em um grupo de pacientes mexicanos com dermatomiosite juvenil. Rev Bras Reumatol. 1998;38:5-8.
25. Peloro TM, Miller OF 3rd, Hahn T F, Newman ED. Juvenile dermatomyositis: a retrospective review of a 30-year experience. J Am Acad Dermatol. 2001;45:28-34.
26. Jäger C, Sirvent N, Rabasse N, Soler C, Sebag F, Boutte P, et al. Juvenile dermatomyositis in the Nice area: a retrospective study 1991-2001. Ann Dermatol Venereol. 2002;129:1120-4.
27. Sallum AM, Kiss MH, Sachetti S, Resende MB, Moutinho KC, Carvalho Mde S, et al. Juvenile dermatomyositis: clinical, laboratorial, histological, therapeutical and evolutive parameters of 35 patients. Arq Neuropsiquiatr. 2002;60:889-99.
28. Mendez E P, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, et al. US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum. 2003;49:300-5.
29. Chowdhary V, Wakhlu A, Agarwal A, Misra R. Outcome in juvenile dermatomyositis. Indian Pediatr. 2002;39:931-5.
30. El-Azhary RA, Pakzad SY. Amyopathic dermatomyositis: retrospective review of 37 cases. J Am Acad Dermatol. 2002;46:560-5.
31. Caproni M, Cardinali C, Parodi A, Giomi B, Papini M, Vaccaro M, et al. Amyopathic dermato-myositis. A review by the Italian group of immunodermatology. Arch Dermatol. 2002;138:23-7.
32. Cosnes A, Amaudric F, Gherardi R, Verroust J, Wechsler J, Revuz J, et al. Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids. Arch Dermatol. 1995;131:1381-5.
33. Trüeb RM. Dermatomyositis. Dermatol Ther. 2001;14:70-80.
34. Naschitz JE, Rosner I, Rozenbaum M, Zuckerman E, Yeshurun D. Rheumatic syndromes: clues to occult neoplasia. Semin Arthritis Rheum. 1999;29:43-55.
35. Yazici Y, Kagen LJ. The association of malignancy with myositis. Curr Opin Rheumatol. 2000;12:498-500.
36. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357:96-100.
37. Jorizzo JL, Carroll CL, Sangueza O P. Dermatomyositis. In: Bologna J, Jorizzo JL, Rapini R P, editors. Dermatology. 2nd ed. London: Mosby; 2008. v.1, p.575-83.
38. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med. 2001;134:1087-95.
39. Pollak DF. Estudo da evolução e prognóstico na dermatopolimiosite. Rev Bras Reumatol. 1986; 26:44-60.
40. Gallais V, Crickx B, Belaich S. Prognostic factors and predictive signs of malignancy in adult dermatomyositis. Ann Dermatol Venereol. 1996;123:722-6.
41. Maoz CR, Langevitz P, Livneh A, Blumstein Z, Sadeh M, Bank I, et al. High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Semin Arthritis Rheum. 1998;27:319-24.
42. Dourmishev LA. Dermatomyositis associated with malignancy. 12 case reports. Adv Exp Med Biol. 1999;455:193-9.
43. Chen YJ, Wu C Y, Shen JL. Predicting factors of malignancy in dermatomyositis and polymyo-sitis: a case-control study. Br J Dermatol. 2001;144:825-31.
44. Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer. 2001;85:41-5.
45. Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P, et al. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Arch Dermatol. 2002;138:885-90.
46. Pinto L F, Angel AM, Bohorquez R, Lopez CM. Caracterizacion de los pacientes con polimiosi-tis y dermatomiositis del Servicio de Reumatologia de Instituto de Seguros Sociales de Medellín, Colombia, 1992-2000. Rev Colomb Reumatol. 2003;10:9-18.
47. Mebazâa A, Boussen H, Nouira R, Rokbani L, Ben Osman-Dhahri A, Bouaouina N, et al. Dermatomyositis and malignancy in Tunisia: A multicenter national retrospective study of 20 cases. J Am Acad Dermatol. 2003;48:530-4.
48. Basset-Seguin N, Roujeau JC, Gherardi R, Guillaume JC, Revuz J, Touraine R. Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases. Arch Dermatol. 1990;126:633-7.
49. Wakata N, Kurihara T, Saito E, Kinoshita M. Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol. 2002;41:729-34.
50. Wong KO. Dermatomyositis: a clinical investigation of twenty-three cases in Hong-Kong. Br J Dermatol. 1969;81:544-7.
51. Marie I, Hatron P Y, Levesque H, Hachulla E, Hellot M F, Michon-Pasturel U, et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore). 1999;78:139-47.
52. Pautas E, Chérin P, Piette JC, Pelletier S, Wechsler B, Cabane J, et al. Features of polymyositis and dermatomyositis in the elderly: a case-control study. Clin Exp Rheumatol. 2000;18:241-4.
53. Hu WJ, Chen DL, Min HQ. Study of 45 cases of nasopharyngeal carcinoma with dermatomyo-sitis. Am J Clin Oncol. 1996;19:35-8.
54. Leow YH, Goh CL. Malignancy in adult dermatomyositis. Int J Dermatol. 1997;36:904-7.
55. Chan HL. Dermatomyositis and cancer: East and West. J Am Acad Dermatol. 2000;42:699-700.
56. Hochberg MC, Feldman D, Stevens MB. Adult polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum. 1986;15:168-78.
57. Douglas WW, Tazelaar HD, Hartman TE, Hartman R P, Decker PA, Schroeder DR, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med. 2001;164:1182-5.
58. Schnabel A, Reuter M, Biederer J, Richter C, Gross WL. Interstitial lung disease in polymyosi-tis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum. 2003;32:273-84.
59. Weitoft T. Occurrence of polymyositis in the county of Gävleborg, Sweden. Scand J Rheumatol. 1997;26:104-6.
60. Kovacs SO, Kovacs SC. Dermatomyositis. J Am Acad Dermatol. 1998;39:899-920.
61. Marie I, Hachulla E, Hatron P Y, Hellot M F, Levesque H, Devulder B, et al. Polymyositis and der-matomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol. 2001;28:2230-7.
62. Jorizzo JL. Dermatomyositis. Practical Aspects. Arch Dermatol. 2002;138:114-6.